487 related articles for article (PubMed ID: 1363009)
21. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
[TBL] [Abstract][Full Text] [Related]
22. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
Hofmann-Lehmann R; Aubert A; Wolfensberger C; Cronier J; Lutz H
Schweiz Arch Tierheilkd; 1994; 136(10):340-51. PubMed ID: 7801087
[TBL] [Abstract][Full Text] [Related]
23. Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms.
Hartmann K; Donath A; Beer B; Egberink HF; Horzinek MC; Lutz H; Hoffmann-Fezer G; Thum I; Thefeld S
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):167-75. PubMed ID: 1363008
[TBL] [Abstract][Full Text] [Related]
24. The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression.
Holznagel E; Hofmann-Lehmann R; Leutenegger CM; Allenspach K; Huettner S; Forster U; Niederer E; Joller H; Willett BJ; Hummel U; Rossi GL; Schüpbach J; Lutz H
J Virol; 1998 Nov; 72(11):9025-33. PubMed ID: 9765447
[TBL] [Abstract][Full Text] [Related]
25. Analysis of leucocytes and lymphocyte subsets for different clinical stages of naturally acquired feline immunodeficiency virus infection.
Walker C; Canfield PJ; Love DN
Vet Immunol Immunopathol; 1994 Dec; 44(1):1-12. PubMed ID: 7725628
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus.
Reche A; Daniel AG; Lazaro Strauss TC; Taborda CP; Vieira Marques SA; Haipek K; Oliveira LJ; Monteiro JM; Kfoury JR
J Feline Med Surg; 2010 Apr; 12(4):355-8. PubMed ID: 20156698
[TBL] [Abstract][Full Text] [Related]
27. Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats.
Podell M; Hayes K; Oglesbee M; Mathes L
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):332-40. PubMed ID: 9342252
[TBL] [Abstract][Full Text] [Related]
28. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.
Torten M; Franchini M; Barlough JE; George JW; Mozes E; Lutz H; Pedersen NC
J Virol; 1991 May; 65(5):2225-30. PubMed ID: 1673159
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.
Coleman JK; Pu R; Martin M; Sato E; Yamamoto JK
AIDS; 2005 Sep; 19(14):1457-66. PubMed ID: 16135898
[TBL] [Abstract][Full Text] [Related]
30. Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections.
Lin DS; Bowman DD; Jacobson RH
J Clin Microbiol; 1992 Jan; 30(1):17-24. PubMed ID: 1346403
[TBL] [Abstract][Full Text] [Related]
31. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
Boretti FS; Leutenegger CM; Mislin C; Hofmann-Lehmann R; König S; Schroff M; Junghans C; Fehr D; Huettner SW; Habel A; Flynn JN; Aubert A; Pedersen NC; Wittig B; Lutz H
AIDS; 2000 Aug; 14(12):1749-57. PubMed ID: 10985311
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.
Hayes KA; Lafrado LJ; Erickson JG; Marr JM; Mathes LE
J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):127-34. PubMed ID: 8381867
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection.
Zenger E; Brown WC; Song W; Wolf AM; Pedersen NC; Longnecker M; Li J; Collisson EW
Am J Vet Res; 1993 May; 54(5):713-8. PubMed ID: 8391229
[TBL] [Abstract][Full Text] [Related]
34. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
[TBL] [Abstract][Full Text] [Related]
35. Effect of primary phase feline immunodeficiency virus infection on cats with chronic toxoplasmosis.
Lappin MR; Gasper PW; Rose BJ; Powell CC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):121-31. PubMed ID: 1363007
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
Maksaereekul S; Dubie RA; Shen X; Kieu H; Dean GA; Sparger EE
Vaccine; 2009 Jun; 27(28):3754-65. PubMed ID: 19464559
[TBL] [Abstract][Full Text] [Related]
37. Duration of antibody response following vaccination against feline immunodeficiency virus.
Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
[TBL] [Abstract][Full Text] [Related]
38. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats.
Burkhard MJ; Valenski L; Leavell S; Dean GA; Tompkins WA
Vaccine; 2002 Dec; 21(3-4):258-68. PubMed ID: 12450701
[TBL] [Abstract][Full Text] [Related]
40. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.
Yang JS; English RV; Ritchey JW; Davidson MG; Wasmoen T; Levy JK; Gebhard DH; Tompkins MB; Tompkins WA
J Virol; 1996 May; 70(5):3011-7. PubMed ID: 8627777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
